Verve Therapeutics (VERV) 424B5 Prospectus supplement for primary offering

Exhibit 107

Calculation of Filing Fee Tables

Form 424(b)(5)

(Form Type)

Verve Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

	Security Type	Security Class Title	Fee Calculation or Carry Forward Rule	Amount Registered(1)	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee(2)	Carry   Forward   Form Type	Carry   Forward   File Number	Carry Forward Initial Effective Date	Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to Be Paid	Equity	Common Stock, $0.001 par value per share	457(r)	14,375,000	$10.00	$143,750,000	0.0001476	$21,217.50	—	—	—	—
Fees Previously Paid	—	—	—	—	—	—	—	—	—	—	—	—
Carry Forward Securities
Carry Forward Securities	—	—	—	—	—	—	—	—	—	—	—	—
	Total Offering Amounts					$143,750,000		$21,217.50
	Total Fees Previously Paid							—
	Total Fee Offsets							—
	Net Fee Due							$21,217.50

(1) Assumes exercise in full of the underwriters’ option to purchase up to 1,875,000 additional shares of common stock.

(2) In accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). This “Calculation of Filing Fee Tables” table shall be deemed to update the table in Item 14 in the registrant’s Registration Statement on Form S-3 (File No. 333-267578) in accordance with Rule 456(b) and 457(r) under the Securities Act.